Orphan Drug for Acanthamoeba Keratitis

Project Information

ODAK

Grant agreement ID: 305661

Project closed

Start date 1 December 2012

End date 30 November 2017

Funded under

• Specific Programme "Cooperation": Health

Total cost

€ 5 779 906,80

EU contribution

€ 4 050 255,00

Coordinated by

UNIVERSITE DE ROUEN NORMANDIE
France

• First drug against a blinding disease that strikes contact lens wearers
  DE EN ES FR IT PL